QH vs IFRX Comparison

Quhuo Ltd is a gig economy platform in China. The company provides tech-enabled, end-to-end operational solutions to consumer service businesses in industries with e-commerce exposure, including food delivery, ride-hailing, housekeeping, bike-sharing, and other services. The company generates revenue predominantly from service fees paid by its industry customers, and to a lesser extent, from rental fees under its car leasing agreements with drivers engaged in the ride-hailing solutions. It derives all of its revenue from the PRC. The company's revenues are categorized into On-demand delivery solutions; Mobility service solutions; Housekeeping solutions and other services. The On-demand delivery solutions generate key revenue for the firm.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.